# Tuberculosis Research Advancement Centers (TRACs) (P30 Clinical Trial Not Allowed)

Source: https://welltoldgrants.com/grants/rfa-ai-27-016-tuberculosis-research-advancement-centers-tracs-p30/  
Official notice: https://www.grants.gov/search-results-detail/361026

> National Institutes of Health offered grants of up to $600,000 to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. It expected to make about 5 awards worth $4.0 million in total. Applications closed on July 10, 2026.

| Field | Value |
|---|---|
| Opportunity number | RFA-AI-27-016 |
| Agency | National Institutes of Health |
| Status | Forecast |
| Deadline | July 10, 2026 |
| Award ceiling | $600,000 |
| Award floor | not stated |
| Expected awards | 5 |
| Total funding | $4.0 million |
| Cost sharing | not required |
| Assistance Listings | 93.855 |

## Who can apply

- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)

Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility. Foreign Organizations/International Collaborations: Non-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement are not allowed.

## What the grant funds

The purpose of this notice of funding opportunity (NOFO) is to support applications for the Tuberculosis (TB) Research Advancement Centers (TRACs) program. The goal of the TRACs is to develop the next generation of TB researchers and to catalyze multidisciplinary and innovative TB science by providing expertise and resources to facilitate basic and clinical TB research.

## Questions people ask

### Is RFA-AI-27-016 still open?

No. It closed on July 10, 2026.

### Who can apply for Tuberculosis Research Advancement Centers (TRACs) (P30 Clinical Trial Not Allowed)?

National Institutes of Health accepted applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Tuberculosis Research Advancement Centers (TRACs) (P30 Clinical Trial Not Allowed)?

Closed July 10, 2026. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

Awards of up to $600,000 each. About $4.0 million in total across about 5 awards.

### Who has won Allergy and Infectious Diseases Research grants before?

The largest recipients over five fiscal years were Fred Hutchinson Cancer Center, Duke University, University of California, Los Angeles. The program made 13,282 awards worth $22 billion in that time.